Springs Capital Master Fund Lp Rock serves as Executive at Homology Medicines, Inc., where they oversee executive responsibilities. Since joining the company, Springs Capital Master Fund Lp Rock has executed 12 insider transactions totaling $25.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 26, 2021 involved exercising options for 756,472 shares valued at $0.
Springs Capital Master Fund Lp Rock currently holds 756,472 shares of Homology Medicines, Inc. (FIXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Springs Capital Master Fund Lp Rock has been a net buyer of FIXX stock. They have purchased $25.0M and sold $0 worth of shares.
Springs Capital Master Fund Lp Rock's most recent insider trade was on Oct 26, 2021, when they sold 756,472 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Oct 26, 2021 | XLO | $8.0M | Purchase | 500,000 | $16.00 | Discretionary |
| Jun 21, 2021 | VERV | $0 | Conversion | 152,926 | $N/A | Discretionary |
| Jun 21, 2021 | VERV | $7.0M | Purchase | 370,000 | $19.00 | Discretionary |
| Jun 21, 2021 | VERV | $0 | Conversion | 556,298 | $N/A | Discretionary |
| Nov 3, 2020 | AVIR | $0 | Conversion | 1,412,016 | $N/A | Discretionary |
| Nov 3, 2020 | AVIR | $0 | Conversion | 282,403 | $N/A | Discretionary |
| Nov 3, 2020 | AVIR | $5.8M | Purchase | 242,708 | $24.00 | Discretionary |
| Nov 3, 2020 | AVIR | $175.0K | Purchase | 7,292 | $24.00 | Discretionary |
| Apr 2, 2018 | FIXX | $4.0M | Purchase | 250,000 | $16.00 | Discretionary |
| Apr 2, 2018 | FIXX | $0 | Conversion | 395,845 | $N/A | Discretionary |